Literature DB >> 1828743

A protocol for screening for diabetic retinopathy in Europe. Retinopathy Working Party.

.   

Abstract

Diabetic eye complications, and particularly diabetic retinopathy, are the major cause of blindness in the working age groups of industrialized countries. Laser photocoagulation has been proven to reduce blindness due to retinopathy by at least 60% but even more patients would benefit if treatment were delivered at an early enough stage. High-risk retinopathy, though, may not cause visual symptoms, and when the latter occur it is often too late to reverse them. Hence, a screening programme for diabetic retinopathy should aim at detecting patients at risk when they can still be effectively treated. This can be achieved by regularly checking the patients' eyes. The screening programme's target, as defined by the joint World Health Organization/International Diabetes Federation Saint Vincent Declaration Working Group, is to reduce diabetes-related blindness by one-third or more in the next 5 years. The number of individuals to be screened is high, 30,000 per million total population per year, but available data indicate that this is feasible and that the initial investments in professional and material resources are more than justified by the reduction of preventable blindness and of the financial burdens that go with it. Indeed, prevention of the major cause of blindness in the working age group should rate the same priority as other widely deployed programmes, such as those to screen for cancer, neonatal hypothyroidism, and phenylketonuria. The concerted action of government health departments, patients' and professional associations will be vital for the successful implementation of this programme.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1991        PMID: 1828743

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  10 in total

1.  Six-year retrospective follow-up study of safe screening intervals for sight-threatening retinopathy in patients with diabetes mellitus.

Authors:  Enrique Soto-Pedre; Maria Concepcion Hernaez-Ortega; José Antonio Vázquez
Journal:  J Diabetes Sci Technol       Date:  2009-07-01

2.  Clinical characteristics influence screening intervals for diabetic retinopathy.

Authors:  Massimo Porta; Mauro Maurino; Sara Severini; Elena Lamarmora; Marina Trento; Elena Sitia; Eleonora Coppo; Alessandro Raviolo; Stefania Carbonari; Marcello Montanaro; Lorenza Palanza; Paola Dalmasso; Franco Cavallo
Journal:  Diabetologia       Date:  2013-07-05       Impact factor: 10.122

3.  Age at onset and the risk of proliferative retinopathy in type 1 diabetes.

Authors:  Kustaa Hietala; Valma Harjutsalo; Carol Forsblom; Paula Summanen; Per-Henrik Groop
Journal:  Diabetes Care       Date:  2010-02-25       Impact factor: 19.112

4.  A nationwide cross-sectional study of retinopathy and microalbuminuria in young Norwegian type 1 (insulin-dependent) diabetic patients.

Authors:  G Joner; O Brinchmann-Hansen; C G Torres; K F Hanssen
Journal:  Diabetologia       Date:  1992-11       Impact factor: 10.122

5.  Visual impairment and blindness in Europe and their prevention.

Authors:  I Kocur; S Resnikoff
Journal:  Br J Ophthalmol       Date:  2002-07       Impact factor: 4.638

6.  Incidence and progression of diabetic retinopathy during 17 years of a population-based screening program in England.

Authors:  Colin D Jones; Richard H Greenwood; Aseema Misra; Max O Bachmann
Journal:  Diabetes Care       Date:  2012-01-25       Impact factor: 19.112

7.  Ocular manifestations of Type 1 diabetes mellitus in pediatric population.

Authors:  Handan Akil; Ayse Derya Buluş; Nesibe Andiran; Mehmet Numan Alp
Journal:  Indian J Ophthalmol       Date:  2016-09       Impact factor: 1.848

Review 8.  Diabetic Retinopathy in Italy: Epidemiology Data and Telemedicine Screening Programs.

Authors:  Stela Vujosevic; Edoardo Midena
Journal:  J Diabetes Res       Date:  2016-11-21       Impact factor: 4.011

Review 9.  Vascular Complication in Adolescents With Diabetes Mellitus.

Authors:  Lara E Graves; Kim C Donaghue
Journal:  Front Endocrinol (Lausanne)       Date:  2020-06-09       Impact factor: 5.555

10.  Heritability of proliferative diabetic retinopathy.

Authors:  Kustaa Hietala; Carol Forsblom; Paula Summanen; Per-Henrik Groop
Journal:  Diabetes       Date:  2008-04-28       Impact factor: 9.461

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.